TY - JOUR AU - Han, Y. AU - Xie, W. AU - Song, D. G. AU - Powell, D. J. PY - 2018 DA - 2018// TI - Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells JO - J Hematol Oncol. VL - 11 UR - https://doi.org/10.1186/s13045-018-0635-z DO - 10.1186/s13045-018-0635-z ID - Han2018 ER - TY - JOUR AU - Dent, R. AU - Trudeau, M. AU - Pritchard, K. I. AU - Hanna, W. M. AU - Kahn, H. K. AU - Sawka, C. A. PY - 2007 DA - 2007// TI - Triple-negative breast cancer: clinical features and patterns of recurrence JO - Clin Cancer Res. VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-3045 DO - 10.1158/1078-0432.CCR-06-3045 ID - Dent2007 ER - TY - JOUR AU - Haffty, B. G. AU - Yang, Q. AU - Reiss, M. AU - Kearney, T. AU - Higgins, S. A. AU - Weidhaas, J. PY - 2006 DA - 2006// TI - Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer JO - J Clin Oncol. VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.5664 DO - 10.1200/JCO.2006.06.5664 ID - Haffty2006 ER - TY - JOUR AU - Diana, A. AU - Franzese, E. AU - Centonze, S. AU - Carlino, F. AU - Della Corte, C. M. AU - Ventriglia, J. PY - 2018 DA - 2018// TI - Triple-negative breast cancers: systematic review of the literature on molecular and clinical features with a focus on treatment with innovative drugs JO - Curr Oncol Rep. VL - 20 UR - https://doi.org/10.1007/s11912-018-0726-6 DO - 10.1007/s11912-018-0726-6 ID - Diana2018 ER - TY - JOUR AU - Carey, L. A. AU - Dees, E. C. AU - Sawyer, L. AU - Gatti, L. AU - Moore, D. T. AU - Collichio, F. PY - 2007 DA - 2007// TI - The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes JO - Clin Cancer Res. VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1109 DO - 10.1158/1078-0432.CCR-06-1109 ID - Carey2007 ER - TY - JOUR AU - Hu, X. AU - Huang, W. AU - Fan, M. PY - 2017 DA - 2017// TI - Emerging therapies for breast cancer JO - J Hematol Oncol. VL - 10 UR - https://doi.org/10.1186/s13045-017-0466-3 DO - 10.1186/s13045-017-0466-3 ID - Hu2017 ER - TY - JOUR AU - Zhao, J. AU - Lin, Q. AU - Song, Y. AU - Liu, D. PY - 2018 DA - 2018// TI - Universal CARs, universal T cells, and universal CAR T cells JO - J Hematol Oncol. VL - 11 UR - https://doi.org/10.1186/s13045-018-0677-2 DO - 10.1186/s13045-018-0677-2 ID - Zhao2018 ER - TY - JOUR AU - Ecker, A. n. d. r. e. a. PY - 2009 DA - 2009// TI - The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor JO - Frontiers in Bioscience VL - Volume UR - https://doi.org/10.2741/3425 DO - 10.2741/3425 ID - Ecker2009 ER - TY - JOUR AU - Puthier, D. AU - Bataille, R. AU - Amiot, M. PY - 1999 DA - 1999// TI - IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway JO - Eur J Immunol. VL - 29 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Puthier1999 ER - TY - JOUR AU - Chang, R. AU - Song, L. AU - Xu, Y. AU - Wu, Y. AU - Dai, C. AU - Wang, X. PY - 2018 DA - 2018// TI - Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis JO - Nat Commun. VL - 9 UR - https://doi.org/10.1038/s41467-018-05852-8 DO - 10.1038/s41467-018-05852-8 ID - Chang2018 ER - TY - STD TI - Shin SY, Choi JH, Jung E, Gil HN, Lim Y, Lee YH. The EGR1-STAT3 transcription factor axis regulates alpha-melanocyte-stimulating hormone induced tyrosinase gene transcription in melanocytes. J Invest Dermatol. 2019. https://doi.org/10.1016/j.jid.2018.12.020. ID - ref11 ER - TY - JOUR AU - Liang, S. AU - Chen, Z. AU - Jiang, G. AU - Zhou, Y. AU - Liu, Q. AU - Su, Q. PY - 2017 DA - 2017// TI - Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-kappaB/IL-6 signals JO - Cancer Lett. VL - 386 UR - https://doi.org/10.1016/j.canlet.2016.11.003 DO - 10.1016/j.canlet.2016.11.003 ID - Liang2017 ER - TY - JOUR AU - Chun, J. AU - Li, R. J. AU - Cheng, M. S. AU - Kim, Y. S. PY - 2015 DA - 2015// TI - Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells JO - Cancer Lett. VL - 357 UR - https://doi.org/10.1016/j.canlet.2014.11.049 DO - 10.1016/j.canlet.2014.11.049 ID - Chun2015 ER - TY - JOUR AU - Kang, D. Y. AU - Sp, N. AU - Kim, D. H. AU - Joung, Y. H. AU - Lee, H. G. AU - Park, Y. M. PY - 2018 DA - 2018// TI - Salidroside inhibits migration, invasion and angiogenesis of MDA-MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2 JO - Int J Oncol VL - 53 ID - Kang2018 ER - TY - JOUR AU - Feng, T. AU - Cao, W. AU - Shen, W. AU - Zhang, L. AU - Gu, X. AU - Guo, Y. PY - 2017 DA - 2017// TI - Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.13393 DO - 10.18632/oncotarget.13393 ID - Feng2017 ER - TY - JOUR AU - Kim, H. S. AU - Kim, T. AU - Ko, H. AU - Lee, J. AU - Kim, Y. S. AU - Suh, Y. G. PY - 2017 DA - 2017// TI - Identification of galiellalactone-based novel STAT3-selective inhibitors with cytotoxic activities against triple-negative breast cancer cell lines JO - Bioorg Med Chem. VL - 25 UR - https://doi.org/10.1016/j.bmc.2017.06.036 DO - 10.1016/j.bmc.2017.06.036 ID - Kim2017 ER - TY - JOUR AU - Kim, S. Y. AU - Kang, J. W. AU - Song, X. AU - Kim, B. K. AU - Yoo, Y. D. AU - Kwon, Y. T. PY - 2013 DA - 2013// TI - Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells JO - Cell Signal. VL - 25 UR - https://doi.org/10.1016/j.cellsig.2013.01.007 DO - 10.1016/j.cellsig.2013.01.007 ID - Kim2013 ER - TY - JOUR AU - Folmer, F. AU - Jaspars, M. AU - Schumacher, M. AU - Dicato, M. AU - Diederich, M. PY - 2010 DA - 2010// TI - Marine natural products targeting phospholipases A2 JO - Biochem Pharmacol. VL - 80 UR - https://doi.org/10.1016/j.bcp.2010.08.024 DO - 10.1016/j.bcp.2010.08.024 ID - Folmer2010 ER - TY - JOUR AU - Schumacher, M. AU - Kelkel, M. AU - Dicato, M. AU - Diederich, M. PY - 2011 DA - 2011// TI - Gold from the sea: marine compounds as inhibitors of the hallmarks of cancer JO - Biotechnol Adv. VL - 29 UR - https://doi.org/10.1016/j.biotechadv.2011.02.002 DO - 10.1016/j.biotechadv.2011.02.002 ID - Schumacher2011 ER - TY - JOUR AU - Martins, A. AU - Vieira, H. AU - Gaspar, H. AU - Santos, S. PY - 2014 DA - 2014// TI - Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success JO - Mar Drugs. VL - 12 UR - https://doi.org/10.3390/md12021066 DO - 10.3390/md12021066 ID - Martins2014 ER - TY - JOUR AU - Ma, J. AU - Huang, H. AU - Xie, Y. AU - Liu, Z. AU - Zhao, J. AU - Zhang, C. PY - 2017 DA - 2017// TI - Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents JO - Nat Commun. VL - 8 UR - https://doi.org/10.1038/s41467-017-00419-5 DO - 10.1038/s41467-017-00419-5 ID - Ma2017 ER - TY - JOUR AU - Choi, H. J. AU - Han, J. S. PY - 2012 DA - 2012// TI - Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells JO - Biochim Biophys Acta. VL - 1823 UR - https://doi.org/10.1016/j.bbamcr.2012.03.015 DO - 10.1016/j.bbamcr.2012.03.015 ID - Choi2012 ER - TY - JOUR AU - Cheng, E. H. AU - Kirsch, D. G. AU - Clem, R. J. AU - Ravi, R. AU - Kastan, M. B. AU - Bedi, A. PY - 1997 DA - 1997// TI - Conversion of Bcl-2 to a Bax-like death effector by caspases JO - Science VL - 278 UR - https://doi.org/10.1126/science.278.5345.1966 DO - 10.1126/science.278.5345.1966 ID - Cheng1997 ER - TY - JOUR AU - Adams, J. M. AU - Cory, S. PY - 2007 DA - 2007// TI - Bcl-2-regulated apoptosis: mechanism and therapeutic potential JO - Curr Opin Immunol VL - 19 UR - https://doi.org/10.1016/j.coi.2007.05.004 DO - 10.1016/j.coi.2007.05.004 ID - Adams2007 ER - TY - JOUR AU - Thornberry, N. A. AU - Lazebnik, Y. PY - 1998 DA - 1998// TI - Caspases: enemies within JO - Science. VL - 281 UR - https://doi.org/10.1126/science.281.5381.1312 DO - 10.1126/science.281.5381.1312 ID - Thornberry1998 ER - TY - JOUR AU - Catlett-Falcone, R. AU - Landowski, T. H. AU - Oshiro, M. M. AU - Turkson, J. AU - Levitzki, A. AU - Savino, R. PY - 1999 DA - 1999// TI - Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells JO - Immunity. VL - 10 UR - https://doi.org/10.1016/S1074-7613(00)80011-4 DO - 10.1016/S1074-7613(00)80011-4 ID - Catlett-Falcone1999 ER - TY - JOUR AU - Hassa, P. O. AU - Hottiger, M. O. PY - 2008 DA - 2008// TI - The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases JO - Front Biosci. VL - 13 UR - https://doi.org/10.2741/2909 DO - 10.2741/2909 ID - Hassa2008 ER - TY - JOUR AU - Kessenbrock, K. AU - Plaks, V. AU - Werb, Z. PY - 2010 DA - 2010// TI - Matrix metalloproteinases: regulators of the tumor microenvironment JO - Cell. VL - 141 UR - https://doi.org/10.1016/j.cell.2010.03.015 DO - 10.1016/j.cell.2010.03.015 ID - Kessenbrock2010 ER - TY - JOUR AU - Satelli, A. AU - Li, S. PY - 2011 DA - 2011// TI - Vimentin in cancer and its potential as a molecular target for cancer therapy JO - Cell Mol Life Sci. VL - 68 UR - https://doi.org/10.1007/s00018-011-0735-1 DO - 10.1007/s00018-011-0735-1 ID - Satelli2011 ER - TY - JOUR AU - Esnakula, A. K. AU - Ricks-Santi, L. AU - Kwagyan, J. AU - Kanaan, Y. M. AU - DeWitty, R. L. AU - Wilson, L. L. PY - 2014 DA - 2014// TI - Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women JO - J Clin Pathol. VL - 67 UR - https://doi.org/10.1136/jclinpath-2013-201698 DO - 10.1136/jclinpath-2013-201698 ID - Esnakula2014 ER - TY - JOUR AU - Carpenter, R. L. AU - Lo, H. W. PY - 2014 DA - 2014// TI - STAT3 target genes relevant to human cancers JO - Cancers (Basel). VL - 6 UR - https://doi.org/10.3390/cancers6020897 DO - 10.3390/cancers6020897 ID - Carpenter2014 ER - TY - JOUR AU - Oh, E. AU - Kim, Y. J. AU - An, H. AU - Sung, D. AU - Cho, T. M. AU - Farrand, L. PY - 2018 DA - 2018// TI - Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition JO - Int J Cancer. VL - 143 UR - https://doi.org/10.1002/ijc.31585 DO - 10.1002/ijc.31585 ID - Oh2018 ER - TY - JOUR AU - Li, W. AU - Zhang, H. AU - Nie, M. AU - Tian, Y. AU - Chen, X. AU - Chen, C. PY - 2017 DA - 2017// TI - Ursolic acid derivative FZU-03,010 inhibits STAT3 and induces cell cycle arrest and apoptosis in renal and breast cancer cells JO - Acta Biochim Biophys Sin (Shanghai). VL - 49 UR - https://doi.org/10.1093/abbs/gmx012 DO - 10.1093/abbs/gmx012 ID - Li2017 ER - TY - JOUR AU - Thiagarajan, P. S. AU - Zheng, Q. AU - Bhagrath, M. AU - Mulkearns-Hubert, E. E. AU - Myers, M. G. AU - Lathia, J. D. PY - 2017 DA - 2017// TI - STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance JO - Endocr Relat Cancer. VL - 24 UR - https://doi.org/10.1530/ERC-16-0349 DO - 10.1530/ERC-16-0349 ID - Thiagarajan2017 ER - TY - JOUR AU - Wu, Y. AU - Diab, I. AU - Zhang, X. AU - Izmailova, E. S. AU - Zehner, Z. E. PY - 2004 DA - 2004// TI - Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89 JO - Oncogene. VL - 23 UR - https://doi.org/10.1038/sj.onc.1207003 DO - 10.1038/sj.onc.1207003 ID - Wu2004 ER - TY - JOUR AU - Liu, J. AU - Liu, L. AU - Yagüe, E. AU - Yang, Q. AU - Pan, T. AU - Zhao, H. PY - 2019 DA - 2019// TI - GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation JO - Breast Cancer Res Treat. VL - 174 UR - https://doi.org/10.1007/s10549-018-5052-z DO - 10.1007/s10549-018-5052-z ID - Liu2019 ER - TY - JOUR AU - Ibrahim, S. A. AU - Gadalla, R. AU - El-Ghonaimy, E. A. AU - Samir, O. AU - Mohamed, H. T. AU - Hassan, H. PY - 2017 DA - 2017// TI - Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways JO - Mol Cancer. VL - 16 UR - https://doi.org/10.1186/s12943-017-0621-z DO - 10.1186/s12943-017-0621-z ID - Ibrahim2017 ER - TY - JOUR AU - Huang, S. P. AU - Liu, P. Y. AU - Kuo, C. J. AU - Chen, C. L. AU - Lee, W. J. AU - Tsai, Y. H. PY - 2017 DA - 2017// TI - The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer JO - J Hematol Oncol. VL - 10 UR - https://doi.org/10.1186/s13045-017-0481-4 DO - 10.1186/s13045-017-0481-4 ID - Huang2017 ER - TY - JOUR AU - O'Reilly, E. A. AU - Gubbins, L. AU - Sharma, S. AU - Tully, R. AU - Guang, M. H. AU - Weiner-Gorzel, K. PY - 2015 DA - 2015// TI - The fate of chemoresistance in triple negative breast cancer (TNBC) JO - BBA Clin. VL - 3 UR - https://doi.org/10.1016/j.bbacli.2015.03.003 DO - 10.1016/j.bbacli.2015.03.003 ID - O'Reilly2015 ER - TY - JOUR AU - Zhang, Z. AU - Min, X. AU - Huang, J. AU - Zhong, Y. AU - Wu, Y. AU - Li, X. PY - 2016 DA - 2016// TI - Cytoglobosins H and I, new antiproliferative cytochalasans from deep-sea-derived fungus Chaetomium globosum JO - Mar Drugs VL - 14 UR - https://doi.org/10.3390/md14120233 DO - 10.3390/md14120233 ID - Zhang2016 ER - TY - JOUR AU - Song, Y. AU - Liu, G. AU - Li, J. AU - Huang, H. AU - Zhang, X. AU - Zhang, H. PY - 2015 DA - 2015// TI - Cytotoxic and antibacterial angucycline- and prodigiosin-analogues from the deep-sea derived Streptomyces sp. SCSIO 11594 JO - Mar Drugs. VL - 13 UR - https://doi.org/10.3390/md13031304 DO - 10.3390/md13031304 ID - Song2015 ER - TY - JOUR AU - Xu, X. AU - Zhang, X. AU - Nong, X. AU - Wang, J. AU - Qi, S. PY - 2017 DA - 2017// TI - Brevianamides and mycophenolic acid derivatives from the deep-sea-derived fungus Penicillium brevicompactum DFFSCS025 JO - Mar Drugs. VL - 15 UR - https://doi.org/10.3390/md15020043 DO - 10.3390/md15020043 ID - Xu2017 ER - TY - JOUR AU - WangC, K. S. AU - Lai, X. AU - Cai, W. AU - Arfuso, F. AU - Sethi, G. PY - 2018 DA - 2018// TI - Triple negative breast cancer in Asia: an insider’s view JO - Cancer Treat Rev VL - 62 UR - https://doi.org/10.1016/j.ctrv.2017.10.014 DO - 10.1016/j.ctrv.2017.10.014 ID - WangC2018 ER - TY - JOUR AU - Chang, Q. AU - Bournazou, E. AU - Sansone, P. AU - Berishaj, M. AU - Gao, S. P. AU - Daly, L. PY - 2013 DA - 2013// TI - The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis JO - Neoplasia. VL - 15 UR - https://doi.org/10.1593/neo.13706 DO - 10.1593/neo.13706 ID - Chang2013 ER - TY - JOUR AU - Kamran, M. Z. AU - Patil, P. AU - Gude, R. P. PY - 2013 DA - 2013// TI - Role of STAT3 in cancer metastasis and translational advances JO - Biomed Res Int. VL - 2013 UR - https://doi.org/10.1155/2013/421821 DO - 10.1155/2013/421821 ID - Kamran2013 ER - TY - JOUR AU - Shah, F. D. AU - Shukla, S. N. AU - Shah, P. M. AU - Shukla, H. K. AU - Patel, P. S. PY - 2009 DA - 2009// TI - Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer JO - Indian J Cancer. VL - 46 UR - https://doi.org/10.4103/0019-509X.52953 DO - 10.4103/0019-509X.52953 ID - Shah2009 ER - TY - JOUR AU - Yamashita, N. AU - Tokunaga, E. AU - Kitao, H. AU - Hisamatsu, Y. AU - Taketani, K. AU - Akiyoshi, S. PY - 2013 DA - 2013// TI - Vimentin as a poor prognostic factor for triple-negative breast cancer JO - J Cancer Res Clin Oncol. VL - 139 UR - https://doi.org/10.1007/s00432-013-1376-6 DO - 10.1007/s00432-013-1376-6 ID - Yamashita2013 ER - TY - JOUR AU - Song, H. AU - Wang, R. AU - Wang, S. AU - Lin, J. PY - 2005 DA - 2005// TI - A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells JO - Proc Natl Acad Sci U S A. VL - 102 UR - https://doi.org/10.1073/pnas.0409894102 DO - 10.1073/pnas.0409894102 ID - Song2005 ER - TY - JOUR AU - Kortylewski, M. AU - Jove, R. AU - Yu, H. PY - 2005 DA - 2005// TI - Targeting STAT3 affects melanoma on multiple fronts JO - Cancer Metastasis Rev. VL - 24 UR - https://doi.org/10.1007/s10555-005-1580-1 DO - 10.1007/s10555-005-1580-1 ID - Kortylewski2005 ER - TY - JOUR AU - Chen, H. AU - Yang, Z. AU - Ding, C. AU - Chu, L. AU - Zhang, Y. AU - Terry, K. PY - 2013 DA - 2013// TI - Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy JO - Eur J Med Chem. VL - 62 UR - https://doi.org/10.1016/j.ejmech.2013.01.023 DO - 10.1016/j.ejmech.2013.01.023 ID - Chen2013 ER - TY - JOUR AU - Wendt, M. K. AU - Balanis, N. AU - Carlin, C. R. AU - Schiemann, W. P. PY - 2014 DA - 2014// TI - STAT3 and epithelial-mesenchymal transitions in carcinomas JO - JAKSTAT. VL - 3 ID - Wendt2014 ER - TY - JOUR AU - Song, Y. AU - Qian, L. AU - Song, S. AU - Chen, L. AU - Zhang, Y. AU - Yuan, G. PY - 2008 DA - 2008// TI - Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene JO - Mol Immunol. VL - 45 UR - https://doi.org/10.1016/j.molimm.2007.04.031 DO - 10.1016/j.molimm.2007.04.031 ID - Song2008 ER - TY - JOUR AU - Xie, T. X. AU - Wei, D. AU - Liu, M. AU - Gao, A. C. AU - Ali-Osman, F. AU - Sawaya, R. PY - 2004 DA - 2004// TI - Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis JO - Oncogene. VL - 23 UR - https://doi.org/10.1038/sj.onc.1207383 DO - 10.1038/sj.onc.1207383 ID - Xie2004 ER - TY - JOUR AU - Dai, X. AU - Yin, C. AU - Zhang, Y. AU - Guo, G. AU - Zhao, C. AU - Wang, O. PY - 2018 DA - 2018// TI - Osthole inhibits triple negative breast cancer cells by suppressing STAT3 JO - J Exp Clin Cancer Res. VL - 37 UR - https://doi.org/10.1186/s13046-018-0992-z DO - 10.1186/s13046-018-0992-z ID - Dai2018 ER - TY - JOUR AU - Dethlefsen, C. AU - Hojfeldt, G. AU - Hojman, P. PY - 2013 DA - 2013// TI - The role of intratumoral and systemic IL-6 in breast cancer JO - Breast Cancer Res Treat. VL - 138 UR - https://doi.org/10.1007/s10549-013-2488-z DO - 10.1007/s10549-013-2488-z ID - Dethlefsen2013 ER - TY - JOUR AU - Guo, Y. AU - Xu, F. AU - Lu, T. AU - Duan, Z. AU - Zhang, Z. PY - 2012 DA - 2012// TI - Interleukin-6 signaling pathway in targeted therapy for cancer JO - Cancer Treat Rev. VL - 38 UR - https://doi.org/10.1016/j.ctrv.2012.04.007 DO - 10.1016/j.ctrv.2012.04.007 ID - Guo2012 ER -